Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2019

Oct 22, 2019

31708_dirs_2019-10-22_0798d223-917f-4b6a-b83d-ddb3cef872e2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2019-10-18

Reporting Person: Roberts David B (Director, President and Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-10-18 Common Stock M 8574 $7.87 Acquired 44583 Direct
2019-10-18 Common Stock M 2845 $11.43 Acquired 47428 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-10-18 Stock Option (Right to Buy) $7.87 M 8574 Disposed 2021-07-24 Common Stock (8574) Direct
2019-10-18 Stock Option (Right to Buy) $11.43 M 2845 Disposed 2022-07-23 Common Stock (2845) Direct

Footnotes

F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

F2: This option is fully vested and exercisable.

F3: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.